Department of Cardiology, Henry Ford Hospital, Detroit, MI 48202, USA.
Department of Cardiology, Freeman Hospital, Newcastle-upon-Tyne, UK.
Curr Cardiol Rev. 2022;18(1):e281221199533. doi: 10.2174/1573403X18666211228095457.
Coronary Artery Calcification (CAC) has been known to be associated with worse Percutaneous Coronary Intervention (PCI) short- and long-term outcomes. Nowadays, with the increased prevalence of the risk factors leading to CAC in the population and also more PCI procedures done in older patients and with the growing number of higher-risk cases of Chronic Total Occlusion (CTO) PCI and PCI after Coronary Artery Bypass Grafting (CABG), severe cases of CAC are now encountered on a daily basis in the catheterization lab and remain a big challenge to the interventional community, making it crucial to identify cases of severe CAC and plan a CAC PCI modification strategy upfront. Improved CAC detection with intravascular imaging helped identify more of these severe CAC cases and predict response to therapy and stent expansion based on CAC distribution in the vessel. Multiple available therapies for CAC modification have evolved over the years. Familiarity with the specifics and special considerations and limitations of each of these tools are essential in the choice and application of these therapies when used in severe CAC treatment. In this review, we discuss CAC pathophysiology, modes of detection, and different available therapies for CAC modification.
冠状动脉钙化 (CAC) 与经皮冠状动脉介入治疗 (PCI) 的短期和长期预后较差有关。如今,随着导致 CAC 的危险因素在人群中的患病率增加,以及更多的 PCI 手术在老年患者中进行,并且慢性完全闭塞 (CTO) PCI 和冠状动脉旁路移植术 (CABG) 后 PCI 的高危病例数量不断增加,严重 CAC 病例现在在导管室中每天都能遇到,这对介入治疗领域来说仍是一个巨大的挑战,因此,确定严重 CAC 病例并提前制定 CAC PCI 修正策略至关重要。血管内成像技术提高了 CAC 的检测能力,有助于识别更多严重 CAC 病例,并根据血管内 CAC 分布情况预测治疗反应和支架扩张情况。多年来,CAC 修正的多种可用疗法不断发展。在严重 CAC 治疗中使用这些疗法时,熟悉每种疗法的具体情况、特殊考虑因素和局限性至关重要。在本文中,我们将讨论 CAC 的病理生理学、检测模式以及 CAC 修正的不同可用疗法。